Bayesian Capital Management’s Meritage Homes MTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,296
Closed -$1.18M 841
2024
Q4
$1.18M Buy
15,296
+4,000
+35% +$365K 0.14% 206
2024
Q3
$1.16M Buy
+11,296
New +$1.07M 0.14% 216
2022
Q2
Sell
-10,896
Closed -$432K 974
2022
Q1
$432K Buy
+10,896
New +$532K 0.06% 416
2021
Q2
Sell
-5,070
Closed -$233K 561
2021
Q1
$233K Buy
+5,070
New +$220K 0.05% 417
2020
Q1
Sell
-19,194
Closed -$586K 908
2019
Q4
$586K Sell
19,194
-7,800
-29% -$268K 0.1% 277
2019
Q3
$950K Buy
+26,994
New +$843K 0.18% 154
2019
Q2
Sell
-9,800
Closed -$219K 629
2019
Q1
$219K Buy
+9,800
New +$210K 0.04% 456

Other funds holding MTH

Bayesian Capital Management's MTH Position: Q1 2025 in Review

Bayesian Capital Management sold out of Meritage Homes (MTH) in Q1 2025, closing a stake of 15,296 shares — an estimated $1.18M sold.

Bayesian Capital Management first reported a position in MTH in Q1 2019 and held it in 7 quarters. The position peaked at $1.18M in Q4 2024. 391 funds tracked by Wall St. Rank hold MTH as of Q1 2025.

  • Bayesian Capital Management reported no remaining Meritage Homes position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 15,296 Meritage Homes shares in Q1 2025, an estimated $1.18M.
  • Bayesian Capital Management first reported a position in Meritage Homes in Q1 2019 and held it in 7 quarters.
  • Bayesian Capital Management's Meritage Homes position peaked at $1.18M in Q4 2024.
  • 391 funds tracked by Wall St. Rank held Meritage Homes as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.